x
ServiziMenu principaleHome
You are here:  > Educational Opportunities > Future Events > Certificate of Advanced Studies in Gynaecological cancers - second cohort
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Certificate of Advanced Studies in Gynaecological cancers - second cohort

01.05.2025  -  18.09.2026

POSTGRADUATE PROGRAMME

Information

Applications open!

The Certificate of Advanced Studies in Gynecological cancers is the first competence programme to focus on advancing the knowledge and science in the management of patients affected by gynaecological cancers.  This programme, which is offered on a part-time basis over 17 months, is divided into three seminars and six online modules.

Upon successful completion of the programme and after passing the final exam, participants will obtain an academic certificate issued by the European School of Oncology and the Università della Svizzera italiana assigning 14 European Credit Transfer and Accumulation System Points (ECTS) and equalling a work load of 381 didactic hours and a diploma supplement issued by the Università della Svizzera italiana.

  • Duration: 17 months
  • Credits assigned: 14 ECTS
  • Structure: 6 online modules + 3 in person seminars
  • Collaborating university: Università della Svizzera italiana (link to USI)
  • Start date next cohort: May 2025
ESCO College Membership

Being selected to take part in this course is one of the ESO activities that gives participants eligibility to enrol in ESO’s College. The course also enables members of the College to earn credits and therefore access more membership benefits. Full and active participation in the course as well as passing the final certificate examination earns participants 400 ESO College credits.

Key Dates
  • Application opening: 1 September 2024
  • Application deadline: 31 December 2024
  • Start date: May 2025 (exact date TBD)
  • Seminar 1: 18 – 21 June, 2025, ESMO Gynaecological cancers Annual Congress, Vienna, Austria
  • Seminar 2: 1 – 5 February, 2026, Learning to Care Seminar, Padova, Italy
  • Seminar 3 and final exam: September 2026 (exact date TBD), Lugano, Switzerland

For further information please contact azampetti@eso.net

LINK TO THE PLATFORM HERE.

Curriculum

Entry requirements

Admission

Admission to the Certificate of Advanced Studies in Gynaecological cancers programme will be by competitive application only.  Applications will be considered if received with all required documents by the published deadline. Attendance is limited to 25 participants per cohort.  Decisions on admissions are made by the appointed Programme Chair.

Attendance

To obtain the Certificate of Advanced Studies in Gynaecological cancers, it will be compulsory that participants will attend all seminars and modules according to the provided time-line.

Insurance

The organisers bear no responsibility for untoward events in relation to the participation in the seminars. Participants are advised to take out their own personal and travel insurance coverage.

Eligibility

The program is designed for medical doctors (medical oncology, radiation oncology, radiology, nuclear medicine or pathology), and surgeons who are engaged in the field of oncology and/or gynaecology, especially in the field of gynaecological cancers.  The following degree is required:

  • Master degree from an accredited college or university in medicine or an equivalent degree at the level of state examination in medicine and have had at least two years residency training in gyneocology in a relevant institution.
  • The following additional achievements will increase the assessment rate of the application:
    • Further professional experience related to the course of studies
    • Completion of an additional qualification in oncology and/or gynaecology (specialist training as a physician or international equivalent)
    • Publications, as evidenced by cumulative impact factors greater than 10
    • At least one year of relevant oncological experience in a foreign country

Application

APPLICATION DEADLINE: 31 DECEMBER 2024

To apply you will need to provide the following documents:

  • Application supplement (template available HERE)
  • Curriculum vitae outlining previous education and professional experience
  • Copy of master’s degree or equivalent degree in medicine or natural sciences or any other study programme covering the same contents in the original language and a certified English translation
  • Copy of transcript of records of the examinations taken during the master’s degree programme in the original language and a certified English translation
  • If the point above is not applicable, please provide a record of all study achievements and examination results obtained in the course of studies until the application deadline
  • Employment verification/reference letters accounting for professional experience in oncology
  • Personal statement, which explains why you believe you are eligible for this programme and how and why it will further support your intended career
  • Supporting documents to verify additional qualifications

Tuition fee

In keeping with the mission of the European School of Oncology, ESO generously subsidizes the cost of the CAS-Gyn programme.  The tuition fee which remains to be paid by each participant is EUR 4’900.  A CAS Financial Aid Fund will be available for participants who cannot cover the full fee directly.

The tuition fee includes:

  • Access to the modules via a dedicated online platform
  • Access to the three in-person seminars foreseen by the programme, including registration for the indicated congresses and accommodation
  • Access to all exams required by the programme

The tuition fee does not include travel to the in-person seminars.

Cancellation

Cancellation should be submitted in writing and will be treated on a case-to-case basis.

Our experts

Chairs
  • Cristiana Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
  • Andrea Papadia, Ospedale Regionale di Lugano, Lugano, Switzerland
  • Alina Sturdza, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Programme Coordinator
  • Ilaria Colombo, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
Conceptual Development and Organisation
  • Alexandra Zampetti, ESO, CH
  • Mina Curcic, USI, CH